• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童期耳聋的遗传学研究。

Genetic investigations in childhood deafness.

作者信息

Parker Michael, Bitner-Glindzicz Maria

机构信息

Sheffield Clinical Genetics Service, Sheffield Children's Hospital NHS Foundation Trust, Sheffield, South Yorkshire, UK.

UCL Institute of Child Health, Genetics and Genomic Medicine Programme, London, UK North East Thames Regional Genetics Service, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.

出版信息

Arch Dis Child. 2015 Mar;100(3):271-8. doi: 10.1136/archdischild-2014-306099. Epub 2014 Oct 16.

DOI:10.1136/archdischild-2014-306099
PMID:25324569
Abstract

Permanent childhood sensorineural hearing loss, is one of the most common birth defects in developed countries. It is important to identify the aetiology of hearing loss for many reasons, as there may be important health surveillance implications particularly with syndromic causes. Non-syndromic sensorineural hearing loss is a highly heterogeneous genetic condition, meaning that it may be caused by any one of numerous genes, with very few phenotypic distinctions between the different genetic types. This has previously presented significant challenges for genetic testing. However, the introduction of new technologies should enable more comprehensive testing in the future, bringing significant benefits to more affected children and their families.

摘要

永久性儿童感音神经性听力损失是发达国家最常见的出生缺陷之一。出于多种原因,确定听力损失的病因很重要,因为这可能对健康监测有重要影响,尤其是对于综合征性病因。非综合征性感音神经性听力损失是一种高度异质性的遗传疾病,这意味着它可能由众多基因中的任何一个引起,不同基因类型之间的表型差异非常小。这以前给基因检测带来了重大挑战。然而,新技术的引入应该能在未来实现更全面的检测,给更多受影响的儿童及其家庭带来巨大益处。

相似文献

1
Genetic investigations in childhood deafness.儿童期耳聋的遗传学研究。
Arch Dis Child. 2015 Mar;100(3):271-8. doi: 10.1136/archdischild-2014-306099. Epub 2014 Oct 16.
2
Republished: Genetic investigations in childhood deafness.再版:儿童耳聋的遗传学研究。
Postgrad Med J. 2015 Jul;91(1077):395-402. doi: 10.1136/postgradmedj-2014-306099rep.
3
[Genetic deafness:the primary cause of sensorineural hearing loss in children].[遗传性耳聋:儿童感音神经性听力损失的主要原因]
Arch Pediatr. 2001 Mar;8(3):308-12. doi: 10.1016/s0929-693x(00)00201-3.
4
Value of genetic testing in the otological approach for sensorineural hearing loss.基因检测在感音神经性听力损失耳科治疗方法中的价值。
Keio J Med. 2009 Dec;58(4):216-22. doi: 10.2302/kjm.58.216.
5
Genetic testing hearing loss: The challenge of non syndromic mimics.遗传性耳聋基因检测:非综合征性耳聋表型模拟的挑战。
Int J Pediatr Otorhinolaryngol. 2021 Nov;150:110872. doi: 10.1016/j.ijporl.2021.110872. Epub 2021 Aug 16.
6
[Family history, clinical features, and molecular characterization of a patient with autosomal recessive non-syndromic hearing loss].[一名常染色体隐性非综合征性听力损失患者的家族史、临床特征及分子特征分析]
Kulak Burun Bogaz Ihtis Derg. 2003 Sep;11(3):85-8.
7
[Genetics of congenital deafness].[先天性耳聋的遗传学]
Med Clin (Barc). 2012 Oct 20;139(10):446-51. doi: 10.1016/j.medcli.2012.02.014. Epub 2012 Apr 24.
8
A novel mutation of the EYA4 gene associated with post-lingual hearing loss in a proband is co-segregating with a novel PAX3 mutation in two congenitally deaf family members.一名先证者中与语后听力损失相关的EYA4基因新突变,在两名先天性耳聋家族成员中与一种新的PAX3突变共同分离。
Int J Pediatr Otorhinolaryngol. 2018 Jan;104:88-93. doi: 10.1016/j.ijporl.2017.10.042. Epub 2017 Oct 31.
9
[Non-syndromic hereditary hearing impairment].[非综合征性遗传性听力损失]
Laryngorhinootologie. 2007 Apr;86(4):299-309; quiz 310-3. doi: 10.1055/s-2007-966309.
10
The Genetic Basis of Nonsyndromic Hearing Loss in Indian and Pakistani Populations.印度和巴基斯坦人群非综合征性听力损失的遗传基础
Genet Test Mol Biomarkers. 2015 Sep;19(9):512-27. doi: 10.1089/gtmb.2015.0023. Epub 2015 Jul 17.

引用本文的文献

1
A treatment-focused approach to medical investigations for hearing loss in infants.针对婴儿听力损失的医学检查的以治疗为重点的方法。
J R Soc N Z. 2024 Sep 11;55(3):547-573. doi: 10.1080/03036758.2024.2399340. eCollection 2025.
2
Noninvasive prenatal diagnosis (NIPD) of non-syndromic hearing loss (NSHL) for singleton and twin pregnancies in the first trimester.孕早期单胎和双胎妊娠非综合征性听力损失(NSHL)的无创产前诊断(NIPD)
Orphanet J Rare Dis. 2025 Jan 27;20(1):40. doi: 10.1186/s13023-025-03558-x.
3
Inner Ear Gene Therapy: An Overview from Bench to Bedside.
内耳基因治疗:从实验台到病床边的概述
Mol Diagn Ther. 2025 Mar;29(2):161-181. doi: 10.1007/s40291-024-00759-1. Epub 2024 Dec 3.
4
Brazilian Society of Otology task force - cochlear implant ‒ recommendations based on strength of evidence.巴西耳科学会特别工作组 - 人工耳蜗植入 - 基于证据强度的建议
Braz J Otorhinolaryngol. 2025 Jan-Feb;91(1):101512. doi: 10.1016/j.bjorl.2024.101512. Epub 2024 Sep 16.
5
Critical role of TPRN rings in the stereocilia for hearing.TPRN环在听觉静纤毛中的关键作用。
Mol Ther. 2024 Jan 3;32(1):204-217. doi: 10.1016/j.ymthe.2023.11.011. Epub 2023 Nov 11.
6
Advances in gene therapy hold promise for treating hereditary hearing loss.基因治疗的进展为遗传性听力损失的治疗带来了希望。
Mol Ther. 2023 Apr 5;31(4):934-950. doi: 10.1016/j.ymthe.2023.02.001. Epub 2023 Feb 8.
7
Task force Guideline of Brazilian Society of Otology ‒ hearing loss in children - Part I ‒ Evaluation.巴西耳科学会工作组指南 - 儿童听力损失 - 第 I 部分 - 评估。
Braz J Otorhinolaryngol. 2023 Jan-Feb;89(1):159-189. doi: 10.1016/j.bjorl.2022.11.002. Epub 2022 Nov 28.
8
Molecular pathology of Usher 1B patient-derived retinal organoids at single cell resolution.单细胞分辨率下的 Usher1B 患者源性视网膜类器官的分子病理学。
Stem Cell Reports. 2022 Nov 8;17(11):2421-2437. doi: 10.1016/j.stemcr.2022.09.006. Epub 2022 Oct 13.
9
Full etiologic spectrum of pediatric severe to profound hearing loss of consecutive 119 cases.连续 119 例儿童重度至极重度听力损失的病因学全貌。
Sci Rep. 2022 Jul 19;12(1):12335. doi: 10.1038/s41598-022-16421-x.
10
Clinical and Genetic Characteristics of Finnish Patients with Autosomal Recessive and Dominant Non-Syndromic Hearing Loss Due to Pathogenic Variants.因致病变异导致常染色体隐性和显性非综合征性听力损失的芬兰患者的临床和遗传特征
J Clin Med. 2022 Mar 26;11(7):1837. doi: 10.3390/jcm11071837.